The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Innovating in Cannabis Space, Closing on Acquisition
- Supreme Cannabis is one of the world’s fastest-growing premium plant-driven lifestyle companies
- Supreme Cannabis has supply agreements in place throughout eight Canadian provinces
- The company gained advanced extraction infrastructure and expertise through its Blissco acquisition
The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) maintains a diversified, international portfolio of distinct cannabis companies, products and brands. Since 2014, it has emerged as one of the world’s fastest-growing, premium, plant-driven, lifestyle companies. The company’s growth strategy includes key industry agreements and its wholly owned 7ACRES subsidiary. Based in Toronto, Ontario, Supreme Cannabis is working to be an innovator in the cannabis sector regarding the design of cultivation facilities and the development of operation excellence metrics.
Supreme Cannabis is Canada’s only licensed cannabis producer that’s primarily focused on premium brands and offers products with coast-to-coast distribution. The company has supply agreements in place throughout eight Canadian provinces. Its 7ACRES subsidiary is its flagship brand. The 7ACRES cultivation facility is among the first 40 of Canada’s federally licensed cannabis producers (http://nnw.fm/1aGdi).
Federally licensed since 2016, 7ACRES operates a 440,000-square-foot cultivation facility in Kincardine, Ontario. 7ACRES’ slogan – ‘Craft Quality, Commercial Scale’ – emphasizes the company’s focus on growing high-quality cannabis in high quantities. As of May 2019, total flowering room space at the operation totaled 230,000 square feet.
Recently, The Supreme Cannabis Company and Blissco Cannabis Corp. announced that the Supreme Court of British Columbia issued a final order approving the earlier announced arrangement between Supreme Cannabis and Blissco (http://nnw.fm/Rxf18). Supreme Cannabis will acquire all of the issued and outstanding common shares of Blissco not already owned by Supreme Cannabis.
With this acquisition, Supreme Cannabis gains advanced extraction infrastructure and expertise. Located in Langley, British Columbia, this 14,000-square-foot production facility has been producing cannabis oils and pre-rolls since receiving its cultivation, cannabis sales and oil production licenses last year.
“With the closing of this acquisition, Supreme Cannabis will expand its portfolio to include a consumer-focused brand that specializes in products for the premium global wellness category,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “In addition to gaining an established wellness brand, Supreme Cannabis will acquire Blissco’s facility built to EU GMP standards that has been extracting oils for the Canadian market since August 2018.”
Furthermore, the company’s investment portfolio includes an equity position and long-term worldwide distribution partnership with Medigrow Lesotho (PTY) Limited in Africa. This partnership’s focus is the export of medical cannabis (CBD) oil to Canada and other global markets in the European Union and South America.
Supreme Cannabis’ growth strategy also includes its C$12 million supply agreement with Tilray Inc. (NASDAQ: TLRY), a worldwide leader in cannabis research, cultivation, processing and distribution. With this agreement, Supreme Cannabis will supply Tilray with dried cannabis in support of medical cannabis patients in Canada for a one-year period.
Supreme Cannabis continues to advance its mission of growing the world’s best cannabis and becoming a leader in the worldwide industry. For investors, the company offers potential ROI with its 7ACRES brand, proprietary technology and products, and passion for cannabis. Supreme Cannabis also continues to look for new opportunities globally as legalization expands beyond Canada.
For more information, visit the company’s website at www.Supreme.ca
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- Supreme Cannabis is one of the world’s fastest-growing premium plant-driven lifestyle companies
- Supreme Cannabis has supply agreements in place throughout eight Canadian provinces
- The company gained advanced extraction infrastructure and expertise through its Blissco acquisition
The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) maintains a diversified, international portfolio of distinct cannabis companies, products and brands. Since 2014, it has emerged as one of the world’s fastest-growing, premium, plant-driven, lifestyle companies. The company’s growth strategy includes key industry agreements and its wholly owned 7ACRES subsidiary. Based in Toronto, Ontario, Supreme Cannabis is working to be an innovator in the cannabis sector regarding the design of cultivation facilities and the development of operation excellence metrics.
Supreme Cannabis is Canada’s only licensed cannabis producer that’s primarily focused on premium brands and offers products with coast-to-coast distribution. The company has supply agreements in place throughout eight Canadian provinces. Its 7ACRES subsidiary is its flagship brand. The 7ACRES cultivation facility is among the first 40 of Canada’s federally licensed cannabis producers (http://nnw.fm/1aGdi).
Federally licensed since 2016, 7ACRES operates a 440,000-square-foot cultivation facility in Kincardine, Ontario. 7ACRES’ slogan – ‘Craft Quality, Commercial Scale’ – emphasizes the company’s focus on growing high-quality cannabis in high quantities. As of May 2019, total flowering room space at the operation totaled 230,000 square feet.
Recently, The Supreme Cannabis Company and Blissco Cannabis Corp. announced that the Supreme Court of British Columbia issued a final order approving the earlier announced arrangement between Supreme Cannabis and Blissco (http://nnw.fm/Rxf18). Supreme Cannabis will acquire all of the issued and outstanding common shares of Blissco not already owned by Supreme Cannabis.
With this acquisition, Supreme Cannabis gains advanced extraction infrastructure and expertise. Located in Langley, British Columbia, this 14,000-square-foot production facility has been producing cannabis oils and pre-rolls since receiving its cultivation, cannabis sales and oil production licenses last year.
“With the closing of this acquisition, Supreme Cannabis will expand its portfolio to include a consumer-focused brand that specializes in products for the premium global wellness category,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “In addition to gaining an established wellness brand, Supreme Cannabis will acquire Blissco’s facility built to EU GMP standards that has been extracting oils for the Canadian market since August 2018.”
Furthermore, the company’s investment portfolio includes an equity position and long-term worldwide distribution partnership with Medigrow Lesotho (PTY) Limited in Africa. This partnership’s focus is the export of medical cannabis (CBD) oil to Canada and other global markets in the European Union and South America.
Supreme Cannabis’ growth strategy also includes its C$12 million supply agreement with Tilray Inc. (NASDAQ: TLRY), a worldwide leader in cannabis research, cultivation, processing and distribution. With this agreement, Supreme Cannabis will supply Tilray with dried cannabis in support of medical cannabis patients in Canada for a one-year period.
Supreme Cannabis continues to advance its mission of growing the world’s best cannabis and becoming a leader in the worldwide industry. For investors, the company offers potential ROI with its 7ACRES brand, proprietary technology and products, and passion for cannabis. Supreme Cannabis also continues to look for new opportunities globally as legalization expands beyond Canada.
For more information, visit the company’s website at www.Supreme.ca
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
